Ischemic Heart Disease in Young Women: JACC Review Topic of the Week

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Sep 1

PMID 36049799

Authors

Margo B Minissian

Puja K Mehta

Sharonne N Hayes

Ki Park

Janet Wei

C Noel Bairey Merz

Leslie Cho

Annabelle Santos Volgman

Islam Y Elgendy

Mamas Mamas

Melinda B Davis

Harmony R Reynolds

Kelly Epps

Kathryn Lindley

Malissa Wood

Odayme Quesada

Gregory Piazza

Carl J Pepine

Affiliations

Soon will be listed here.

Abstract

The Cardiovascular Disease in Women Committee of the American College of Cardiology convened a working group to develop a consensus regarding the continuing rise of mortality rates in young women aged 35 to 54 years. Heart disease mortality rates in young women continue to increase. Young women have increased mortality secondary to ischemic heart disease (IHD) compared with comparably aged men and similar mortality to that observed among older women. The authors reviewed the published evidence, including observational and mechanistic/translational data, and identified knowledge gaps pertaining to young women. This paper provides clinicians with pragmatic, evidence-based management strategies for young women at risk for IHD. Next-step research opportunities are outlined. This report presents highlights of the working group review and a summary of suggested research directions to advance the IHD field in the next decade.

Citing Articles

Toxic stress is associated with cardiovascular disease among younger but not older women in the United States: Results from the research goes red registry.

Honarvar S, Sullivan S Prev Med Rep. 2025; 51:102992.

PMID: 39990202 PMC: 11846576. DOI: 10.1016/j.pmedr.2025.102992.

Outcomes of Guideline-Recommended Percutaneous Coronary Intervention in Women with Obstructive Coronary Artery Disease: A Longitudinal Cohort Study.

Delamain T, Delamain J, Braga S, Costa R, Siqueira D, Feres F Arq Bras Cardiol. 2025; 122(1):e20240249.

PMID: 39907376 PMC: 11805569. DOI: 10.36660/abc.20240249.

Traditional and Non-Traditional Risk Factors of Acute Coronary Syndrome in Young Women: Evidence from the ANCORS-YW Study.

Ibdah R, Al-Nusair M, Abuhalimeh R, Mahmoud S, Laswi B, Rawashdeh S Int J Womens Health. 2025; 17:139-152.

PMID: 39876840 PMC: 11774101. DOI: 10.2147/IJWH.S479229.

Gender-Specific Insights into Depression in Patients with Ischemic Heart Disease: Findings from a Pilot Study Using a Self-Developed Questionnaire.

Bondar L, Osser B, Miuta C, Petran D, Baltean A, Butari D Diseases. 2024; 12(12.

PMID: 39727650 PMC: 11727549. DOI: 10.3390/diseases12120320.

Prediction of Major Adverse Coronary Events Using the Coronary Risk Score in Women.

Romero-Farina G, Aguade-Bruix S, Ferreira-Gonzalez I Radiol Cardiothorac Imaging. 2024; 6(6):e230381.

PMID: 39636220 PMC: 11683203. DOI: 10.1148/ryct.230381.

References

Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J . Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988; 78(1):1-9. DOI: 10.1161/01.cir.78.1.1. View

Ananth C, Duzyj C, Yadava S, Schwebel M, Tita A, Joseph K . Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010. Hypertension. 2019; 74(5):1089-1095. DOI: 10.1161/HYPERTENSIONAHA.119.12968. View

AlBadri A, Merz C, Johnson B, Wei J, Mehta P, Cook-Wiens G . Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. J Am Coll Cardiol. 2019; 73(6):684-693. PMC: 6383781. DOI: 10.1016/j.jacc.2018.11.040. View

Alshurafa N, Sideris C, Pourhomayoun M, Kalantarian H, Sarrafzadeh M, Eastwood J . Remote Health Monitoring Outcome Success Prediction Using Baseline and First Month Intervention Data. IEEE J Biomed Health Inform. 2016; 21(2):507-514. DOI: 10.1109/JBHI.2016.2518673. View

Beltrame J, Crea F, Kaski J, Ogawa H, Ong P, Sechtem U . International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2015; 38(33):2565-2568. DOI: 10.1093/eurheartj/ehv351. View

Romagnoli E, Lanza G . Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications. Int J Cardiol. 2006; 117(1):3-5. DOI: 10.1016/j.ijcard.2006.10.001. View

Maddox T, Ho P, Roe M, Dai D, Tsai T, Rumsfeld J . Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010; 3(6):632-41. DOI: 10.1161/CIRCOUTCOMES.109.906214. View

Ford T, Yii E, Sidik N, Good R, Rocchiccioli P, McEntegart M . Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders. Circ Cardiovasc Interv. 2019; 12(12):e008126. PMC: 6924940. DOI: 10.1161/CIRCINTERVENTIONS.119.008126. View

Patel J, Pallazola V, Dudum R, Greenland P, McEvoy J, Blumenthal R . Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021; 6(10):1161-1170. PMC: 8281019. DOI: 10.1001/jamacardio.2021.2321. View

10.

Stehli J, Martin C, Brennan A, Dinh D, Lefkovits J, Zaman S . Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention. J Am Heart Assoc. 2019; 8(10):e012161. PMC: 6585344. DOI: 10.1161/JAHA.119.012161. View

11.

Pepine C, Anderson R, Sharaf B, Reis S, Smith K, Handberg E . Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010; 55(25):2825-32. PMC: 2898523. DOI: 10.1016/j.jacc.2010.01.054. View

12.

Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskjold A, Gard A . Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation. 2017; 135(16):1481-1489. DOI: 10.1161/CIRCULATIONAHA.116.026336. View

13.

Safdar B, Spatz E, Dreyer R, Beltrame J, Lichtman J, Spertus J . Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study. J Am Heart Assoc. 2018; 7(13). PMC: 6064896. DOI: 10.1161/JAHA.118.009174. View

14.

Bangalore S, Fonarow G, Peterson E, Hellkamp A, Hernandez A, Laskey W . Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012; 125(10):1000-9. DOI: 10.1016/j.amjmed.2011.11.016. View

15.

Pirozzolo G, Seitz A, Athanasiadis A, Bekeredjian R, Sechtem U, Ong P . Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA). Clin Res Cardiol. 2019; 109(2):246-254. DOI: 10.1007/s00392-019-01507-w. View

16.

Merz C, Pepine C, Walsh M, Fleg J . Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017; 135(11):1075-1092. PMC: 5385930. DOI: 10.1161/CIRCULATIONAHA.116.024534. View

17.

Humphries K, Lee M, Izadnegahdar M, Gao M, Holmes D, Scheuermeyer F . Sex Differences in Diagnoses, Treatment, and Outcomes for Emergency Department Patients With Chest Pain and Elevated Cardiac Troponin. Acad Emerg Med. 2017; 25(4):413-424. DOI: 10.1111/acem.13371. View

18.

Beltrame J, Crea F, Kaski J, Ogawa H, Ong P, Sechtem U . The Who, What, Why, When, How and Where of Vasospastic Angina. Circ J. 2015; 80(2):289-98. DOI: 10.1253/circj.CJ-15-1202. View

19.

Beltrame J, Sasayama S, Maseri A . Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999; 33(6):1442-52. DOI: 10.1016/s0735-1097(99)00073-x. View

20.

Wei J, Mehta P, Johnson B, Samuels B, Kar S, Anderson R . Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv. 2012; 5(6):646-53. PMC: 3417766. DOI: 10.1016/j.jcin.2012.01.023. View